Showing BioInteractions for Omega-3 fatty acids (DB11133)
BioInteractor utilizes data on drug-target, -enzyme and -transporter associations to provide insight on drug-drug interactions. It allows you to identify, for instance, which drugs act similarly on the same target. Such drugs may have additive pharmacodynamic effects if given concomitantly. Conversely, two drugs may antagonize the beneficial effects of each other by having opposite actions on a specific drug target. BioInteractor uses ranked drug-enzyme association information to predict enzyme-mediated drug interactions that may be clinically relevant.
Interacting Group | Interacting Drugs | |
---|---|---|
Omega-3 fatty acids is a Peroxisome proliferator-activated receptor gamma ligand | ||
1 | Peroxisome proliferator-activated receptor gamma agonists | Aleglitazar, Amiodarone, Balsalazide, Bezafibrate, Darglitazone, Flufenamic acid, Glipizide, Icosapent, Isoflavone, Mesalazine, Mitiglinide, Nateglinide, Pioglitazone, Repaglinide, Rosiglitazone, Sulfasalazine, Troglitazone |
2 | Peroxisome proliferator-activated receptor gamma partial agonists | AMG-131, Telmisartan |
3 | Peroxisome proliferator-activated receptor gamma activators | Cannabidiol, Dexibuprofen, Ibuprofen, Indomethacin, Lobeglitazone |
4 | Peroxisome proliferator-activated receptor gamma ligands | Capric acid, Doconexent, Oleic Acid |
5 | Peroxisome proliferator-activated receptor gamma modulators | Clofazimine |
Interacting Group | Interacting Drugs | |
---|---|---|
Omega-3 fatty acids is a Peroxisome proliferator-activated receptor alpha activator | ||
1 | Peroxisome proliferator-activated receptor alpha agonists | Aleglitazar, Amiodarone, Bezafibrate, Cardarine, Clofibrate, Fenofibrate, Fenofibric acid, Gemfibrozil, Indomethacin, Isoflavone, Myrrh |
2 | Peroxisome proliferator-activated receptor alpha activators | Fenoprofen, Flufenamic acid, Ibuprofen, Leukotriene B4, Prasterone, Soybean oil |
3 | Peroxisome proliferator-activated receptor alpha ligands | Doconexent |
Interacting Group | Interacting Drugs | |
---|---|---|
Omega-3 fatty acids is a Sterol regulatory element-binding protein 1 inhibitor | ||
1 | Sterol regulatory element-binding protein 1 inhibitors | Doconexent, Omega-3-acid ethyl esters |
Interacting Group | Interacting Drugs | |
---|---|---|
Omega-3 fatty acids is a Arachidonate 5-lipoxygenase substrate | ||
1 | Arachidonate 5-lipoxygenase inhibitors | Aminosalicylic acid, Balsalazide, Cannabidiol, Diacerein, Diethylcarbamazine, Fostamatinib, Hyperforin, Masoprocol, Meclofenamic acid, Medical Cannabis, Mesalazine, Minocycline, Morniflumate, Nabiximols, Rhein, Sulfasalazine, Zileuton |
2 | Arachidonate 5-lipoxygenase substrates | Omega-6 fatty acids |
3 | Arachidonate 5-lipoxygenase antagonists | Morniflumate |
4 | Arachidonate 5-lipoxygenase potentiators | Diclofenac |